Skip to main content
. 2016 Nov;13(11):2045–2056. doi: 10.1513/AnnalsATS.201606-426FR

Figure 2.

Figure 2.

Absolute observed changes from baseline in FVC % predicted by treatment arm (all observed data, intention-to-treat principle applied) (63). Group A, cyclophosphamide (CYC); group B, mycophenolate mofetil (MMF). Vertical bars represent the SEM.